Opportunity Information: Apply for RFA FD 15 040
Apply for RFA FD 15 040
- The Food Drug Administration in the consumer protection food and nutrition health sector is offering a public funding opportunity titled "Program Expansion for Fostering Cooperation and Strengthening Medical Product Regulatory Systems in the Americas to add a Medical Device Module for Secure Regulatory Information Exchange (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103 Food and Drug AdministrationResearch.
- This funding opportunity was created on Jul 10, 2015 and posted on May 14, 2015.
- Applicants must submit their applications by Jul 17, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Only the following organization is eligible to apply The Pan American Health Organization (PAHO)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, RFA FD 15 040, is a discretionary cooperative agreement from the U.S. Food and Drug Administration (CFDA 93.103) designed as a program expansion of an earlier FDA initiative (RFA FD 15 002) that focused on strengthening medical product regulatory systems and promoting regulatory cooperation across the Americas. The underlying goal is to improve regulatory capacity and collaboration in ways that directly support the FDA's public health mission, especially by improving how regulators generate, share, and use evidence for regulatory decisions. A central theme is the development and strengthening of data and information systems that can serve as reliable inputs for evidence-based regulatory actions.
The expanded scope introduced in this announcement centers specifically on medical devices and adds a medical device module to enable secure regulatory information exchange. The intent is to support development of an international, collaborative portal that participating regulators and partners can use to share and analyze medical device-related information. The portal is meant to handle high-value regulatory data such as audits of medical device manufacturers and assessments of organizations that perform auditing functions. In practical terms, the opportunity emphasizes building infrastructure that helps regulators compare findings, track compliance-related activities, and use shared information to inform oversight and decision-making across different jurisdictions.
A key requirement of the expanded work is that information exchanges through the portal must be effective, traceable, and secure. "Effective" implies the system should be usable and support real regulatory workflows rather than acting as a simple document repository. "Traceable" signals that the system should maintain clear records or audit trails showing what information was shared, by whom, and when, supporting accountability and confidence in the data. "Secure" highlights the need to protect sensitive regulatory information, which may include non-public details about manufacturers, audit results, and organizational performance. The announcement also stresses that the portal should be scalable so it can support both current participants and future growth, and that it should conform to appropriate data transmission standards so information can move reliably between organizations and systems without creating technical barriers.
The award structure is a cooperative agreement (U01), which generally indicates substantial involvement by the funding agency compared with a standard grant. While the summary text does not list detailed deliverables, the cooperative agreement format typically reflects an expectation of close coordination with FDA on planning, technical direction, and alignment with broader regulatory collaboration goals. The overall projected funding is up to $1,000,000, with an award ceiling of $1,000,000, and the FDA anticipated making one award. There is no cost-sharing or matching requirement stated.
Eligibility is narrowly limited: only the Pan American Health Organization (PAHO) is eligible to apply. This reflects the regional, multinational nature of the effort and positions PAHO as the coordinating entity for implementing and convening the collaborative work across the Americas. Administrative details provided in the source include a posted date of May 14, 2015, a current closing date of July 17, 2015, and an archive date of July 31, 2015. The listed FDA contact for access issues with the full announcement is Kimberly Pendleton Chew, Chief Grants Management Officer, at kimberly.pendleton@fda.hhs.gov.
Frequently Asked Questions (FAQs)
What is the funding opportunity number and program type?
The opportunity is RFA FD 15 040. It is a discretionary cooperative agreement from the U.S. Food and Drug Administration (FDA) under CFDA 93.103.
What kind of award is this?
This is a cooperative agreement (U01). A cooperative agreement typically involves substantial involvement by the funding agency (FDA) compared with a standard grant, including closer coordination on planning, technical direction, and alignment with program goals.
What is the purpose of this funding opportunity?
The purpose is to expand an earlier FDA initiative (RFA FD 15 002) that focused on strengthening medical product regulatory systems and promoting regulatory cooperation across the Americas. The expansion emphasizes improving regulatory capacity and collaboration by improving how regulators generate, share, and use evidence for regulatory decisions.
What is the central theme of the expanded work?
A central theme is developing and strengthening data and information systems that can serve as reliable inputs for evidence-based regulatory actions, with a specific new focus on medical devices.
How does RFA FD 15 040 relate to RFA FD 15 002?
RFA FD 15 040 is described as a program expansion of the earlier FDA initiative RFA FD 15 002. The new announcement expands the scope by adding a medical device module and focusing on secure regulatory information exchange for medical device-related information.
What specific area is added in this expanded scope?
The expanded scope centers specifically on medical devices and introduces a medical device module designed to enable secure regulatory information exchange.
What is the main system or tool this funding supports?
The funding supports development of an international, collaborative portal that participating regulators and partners can use to share and analyze medical device-related information.
What kinds of information is the portal expected to handle?
The portal is intended to handle high-value regulatory data such as audits of medical device manufacturers and assessments of organizations that perform auditing functions.
What practical regulatory uses are envisioned for the portal?
The portal is meant to help regulators compare findings, track compliance-related activities, and use shared information to inform oversight and decision-making across different jurisdictions.
What does the opportunity mean by information exchange being "effective"?
"Effective" implies the portal should be usable and support real regulatory workflows, rather than functioning as a simple document repository.
What does "traceable" mean in the context of this portal?
"Traceable" indicates the portal should maintain clear records or audit trails showing what information was shared, by whom, and when. This supports accountability and confidence in the shared data.
What does "secure" mean in the context of this portal?
"Secure" highlights the need to protect sensitive regulatory information that may include non-public details about manufacturers, audit results, and organizational performance.
Are there any expectations around scalability?
Yes. The announcement stresses that the portal should be scalable so it can support current participants and future growth.
Are there expectations around data transmission standards?
Yes. The portal is expected to conform to appropriate data transmission standards so information can move reliably between organizations and systems without creating technical barriers.
How much funding is available?
The overall projected funding is up to $1,000,000, and the award ceiling is $1,000,000.
How many awards does FDA anticipate making?
FDA anticipated making one award under this opportunity.
Is there any cost-sharing or matching requirement?
No cost-sharing or matching requirement is stated in the provided information.
Who is eligible to apply?
Eligibility is narrowly limited to the Pan American Health Organization (PAHO) only.
Why is eligibility limited to PAHO?
Based on the provided information, the limitation reflects the regional, multinational nature of the effort and positions PAHO as the coordinating entity for implementing and convening collaborative work across the Americas.
What are the key dates for this opportunity?
The posted date is May 14, 2015. The closing date is July 17, 2015. The archive date is July 31, 2015.
Who is the FDA contact listed for access issues with the full announcement?
The listed contact is Kimberly Pendleton Chew, Chief Grants Management Officer. Email: kimberly.pendleton@fda.hhs.gov.
What FDA program identifier is included with this opportunity?
The opportunity references CFDA 93.103.
What is the overall public health goal connected to FDA's mission?
The goal is to improve regulatory capacity and collaboration in ways that directly support FDA's public health mission, particularly by improving how regulators generate, share, and use evidence for regulatory decisions.
Browse more opportunities from the same category: Consumer Protection Food and Nutrition Health
Next opportunity: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01)
Previous opportunity: Community Services Block Grant (CSBG) State and Eligible Entity Technical Assistance Services
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA FD 15 040
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA FD 15 040) also looked into and applied for these:
| Funding Opportunity |
|---|
| Evaluating Quality Metrics for Risk Based Surveillance of Drug Manufacturing Operations and Facilities (U01) Apply for RFA FD 15 036 Funding Number: RFA FD 15 036 Agency: Food Drug Administration Category: Consumer Protection Food and Nutrition Health Funding Amount: $500,000 |
| Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Apply for RFA FD 15 014 Funding Number: RFA FD 15 014 Agency: Food Drug Administration Category: Consumer Protection Food and Nutrition Health Funding Amount: $500,000 |
| Smokeless Tobacco Reference Products (UC2) Apply for RFA FD 15 026 Funding Number: RFA FD 15 026 Agency: Food Drug Administration Category: Consumer Protection Food and Nutrition Health Funding Amount: $3,000,000 |
| Building towards Statistically Based Pharmaceutical Quality Standards (U01) Apply for RFA FD 16 003 Funding Number: RFA FD 16 003 Agency: Food Drug Administration Category: Consumer Protection Food and Nutrition Health Funding Amount: $1,000,000 |
| Evaluating Quality Metrics for Risk Based Surveillance of Drug Manufacturing Operations and Facilities (U01) Apply for RFA FD 16 004 Funding Number: RFA FD 16 004 Agency: Food Drug Administration Category: Consumer Protection Food and Nutrition Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 15 040", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
